Explore the Science, Partnerships & Insights Defining the Next Generation of ADCs

The 17th World ADC London is Europe's largest and most influential gathering dedicated to antibody-drug conjugates, bringing together the people, partnerships and insights driving the next generation of ADC innovation.

Download the Preliminary Agenda to explore the companies, speakers, scientific breakthroughs and networking opportunities defining the future of ADC development. Discover how the industry is responding to increasing clinical competition, resistance mechanisms and the drive to create differentiated ADCs capable of becoming the future standard of care.

This is your opportunity to see where the ADC industry is heading next and how the leading players plan to get there.

Download Your Preliminary Agenda Today

Brochure Cover - 17th World ADC London

Having trouble downloading the brochure? Let us know and we'll email it to you instead.

Global ADC Speaker Faculty Pharma, Biotech & Academia

Global Pharmaceutical Companies

Pfizer Logo - 16th World ADC London Summit
AstraZeneca Logo - 16th World ADC London Summit
Logo of Boehringer Ingelheim
BeOne Logo - 16th World ADC London Summit
daiichi sankyo Logo - 16th World ADC London Summit
Roche Logo - 16th World ADC London Summit
GSK Logo - 16th World ADC London Summit

Global Biotech Companies

Logo of Innovent Biologics
Logo of Hummingbird Bioscience
Logo of Tagworks Pharmaceuticals
Logo of Iksuda Therapeutics
Logo of Araris
Oxford Bio Logo - 16th World ADC London Summit
Logo of Araris

World ADC London brings together the leaders and innovators shaping the future of antibody–drug conjugates. For me, the value lies in the quality of the dialogue, exchanging perspectives on where the field is heading, identifying opportunities for collaboration and ensuring that innovation continues to translate into meaningful outcomes for patients.

Chief Executive Officer, Araris Biotech